tirzepatide news november 2025 In adults with obesity but not diabetes, leads to significantly greater weight loss than semaglutide over 72 weeks, and nearly double the patients on tirzepatide meet the 25% weight-loss target. http://ms.spr.ly/6183SkuIL Tirzepatide Reduces Food Intake and

How this should shape your decision and monitoring For most people without a pancreatitis history, the evidence does not support avoiding a GLP-1 out of fear of the pancreas

Build habits and metabolic resilience while the medication provides a metabolic advantage

Incorporate resistance training into your workouts, experiment with new healthy recipes, or adjust your meal timing to give your metabolism a little nudge

Like the obesity drugs themselves, GLP-1 supplements are meant to be taken continuously

The overarching issue is that compounded medications are not FDA-approved, which means their safety, efficacy, and quality are less predictable, says Dr

Promised safety routine can be provided if you need